Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 701 - 750 out of 17,226

Document Document Title
WO/2014/010700A1
The purpose of the present invention is to provide: an amino compound of an amino acid derivative, a peptide or the like, which is produced by derivatizing a glycated protein decomposition product derivative including a final glycation p...  
WO/2013/151467A3
The invention relates to biochemistry and biotechnology and is directed to producing peptides with sex- and sexual-function-stimulating activity of general formula: A-Thr-Lys-Pro-B-C-D-Х, where А is 0, Met, Met(0), Thr, Ala, His, Ph...  
WO/2013/132317A9
The present invention relates to novel peptidomimetic compounds as therapeutic agents capable of inhibiting the programmed cell death 1 (PD1) signalling pathway. The invention also relates to derivatives of the therapeutic agents. The in...  
WO/2014/002571A1
[Problem] To provide a useful dipeptide-containing composition derived from dried bonito flakes and the like, having an angiotensin-converting-enzyme inhibiting activity that imparts a blood pressure reducing function. [Solution] A compo...  
WO/2013/189978A1
The invention relates to a process for preparing β-amino acid derivatives, which process can be used for the preparation of telaprevir or a pharmaceutically acceptable salt or solvate thereof, wherein the process includes an organocatal...  
WO/2013/191926A1
The present invention relates to methods of preparing β-turn cyclic peptidomimetic compounds and intermediates thereof. Particularly, the present invention relates to a process for the synthesis of β-turn cyclic peptidomimetic compound...  
WO/2013/188607A1
A selective method of modifying the N-terminus a protein using an aminoacyl tRNA transferase is provided. The method comprises reacting the protein with the aminoacyl adenosyl derivative, recognizable by AaT t-RNA transferase derived fro...  
WO/2013/185090A1
Provided are compounds of Formula (I) and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of virus infections, particularly hepatitis C infections.  
WO/2013/184958A1
The present invention relates to a chimeric protein that includes an N-terminus coupled to a C-terminus, where the N-terminus includes a portion of a paracrine fibroblast growth factor ("FGF") and the C-terminus includes a C-terminal por...  
WO/2013/184962A1
The present invention relates to a chimeric protein that includes an N-terminus coupled to a C-terminus, where the N-terminus includes a portion of a paracrine fibroblast growth factor ("FGF") and the C-terminus includes a C-terminal por...  
WO/2013/178682A2
It is described a general process, along with its possible variants, for the production of the compounds Telaprevir (I) and Boceprevir (II).  
WO/2013/177293A1
The present invention provides compounds of Formula (I) and (II): (I) (II) wherein R1, R2, R4, R5, R6, X and n are as defined herein, and wherein R3 is hydrogen or a sulfur protecting group. Compounds of Formula (I) and (II), wherein R i...  
WO/2013/171595A1
This invention provides novel compounds and methods for promoting cell survival and/or plasticity, especially in neuronal cells, by targeting the microtubule End Binding (EB) proteins and other associated proteins (e.g., drebrin). Method...  
WO/2013/172728A1
The invention relates to medicine and, more particularly, to agents for correcting metabolic syndrome. The proposed agent for correcting metabolic syndrome is in the form of the tripeptide L-lysyl-L-glutamyl-L-tryptophan of general formu...  
WO/2003/006605A9  
WO/2013/132317A8
The present invention relates to novel peptidomimetic compounds as therapeutic agents capable of inhibiting the programmed cell death 1 (PD1) signalling pathway. The invention also relates to derivatives of the therapeutic agents. The in...  
WO/2013/165262A1
The invention relates to novel peptides and constructs. In addition, the invention provides methods for delivery of one or more compound to a cell. The peptides and constructs may be used for the delivery of compounds to cells in vitro a...  
WO/2013/163858A1
Provided is a lipopeptide, comprising a peptide chain and an aliphatic chain connected through a peptide bond. The molecular weight of the lipopeptide is 2848Da, and the lipopeptide is linear, and can obviously introduce the expression o...  
WO/2002/077001A9  
WO/2002/064559A3
Compounds of the invention are useful in inhibiting thrombin and associated thrombotic occlusions having the following structure Formula (I): wherein u is CH or N; Q is 1)-N(R25)CH(R30)- wherein the nitrogen atom is attached to R1, and R...  
WO/2013/124701A3
The present invention relates to conformationally constrained homo- and heterodimeric mimetics of Smac with function as inhibitors of Inhibitor of Apoptosis Proteins (IAPs), the invention also relates to the use of these compounds in the...  
WO/2013/155595A1
Provided are a crystal form of the mono sodium salt of H-D-Glu(L-Trp-OH)-OH of formula:(Formula (I)) and processes for making the mono sodium salt of H-D-Glu(L-Trp-OH)-OH.  
WO/2013/155592A1
Crystalline forms of golotimod of the chemical structure: (I) and processes for their manufacture are provided.  
WO/2012/140500A9
The present invention relates to compounds of Formula I, II, IA-VA, IVA1-1VA5, 11IA1-IIIA5 and their pharmaceutical uses. Particular aspects of the invention relate to the use of those compounds for the selective inhibition of one or mor...  
WO/2013/158600A1
Novel peptoid oligomers are disclosed that have a formula represented by the following formula la or lb: ( l ) The peptoid oligomers are prepared as modulators of androgen receptor (AR), and may be prepared as pharmaceutical compositions...  
WO/2013/156493A1
Compounds of general formula (I): Ri-Wn-Xm-AAi-AA2-AA3-AA4-AA5-AA6-Yp-Zq-R2 (I ) their stereoisomers, mixtures thereof and/or their cosmetically or pharmaceutically acceptable salts, preparation processes, cosmetic and/or pharmaceutical ...  
WO/2013/152688A1
The present invention relates to a separation and purification method for an organic compound in the chemical field. Specifically, the present invention relates to a separation and purification method for dalfopristin and an intermediate...  
WO/2013/154208A1
The present invention addresses the issue of providing a method which enables the identification and quantification of types of animal hair from a sample containing animal hair by directly analyzing protein which is the main component of...  
WO/2013/151467A2
The invention relates to biochemistry and biotechnology and is directed to producing peptides with sex- and sexual-function-stimulating activity of general formula: A-Thr-Lys-Pro-B-C-D-Х, where А is 0, Met, Met(0), Thr, Ala, His, Ph...  
WO/2013/140902A1
Provided is a gelator which can gelate a wide variety of solvents including water and organic solvents through the self organization of molecules of the gelator, even when added in a small quantity, and which can disperse and gelate an a...  
WO/2013/142088A1
Disclosed are peptides having biological and therapeutic activity. Particularly disclosed are lipidated di- or tri- peptides analogs of KPV or KdPT that exhibit antimicrobial activity. In particular, the peptides of this invention provid...  
WO/2013/142229A1
The technology described herein relates to methods and compositions relating to the modulation of the extacellular matrix and fibronectin and peptides provided herein for such uses.  
WO/2013/140388A1
The present invention provides novel short peptides that are highly effective in inducing involution in a mammary gland of a lactating mammal and cessation of milk production by the gland. The invention further provides pharmaceutical co...  
WO/2013/137302A1
This lysine oligomer derivative is made by linking the ε-amino group and the carboxyl group of lysine by peptide linkage, and is characterized in that a group capable of generating or absorbing an electromagnetic wave is bonded to the C...  
WO/2013/138474A1
A peptide of the general structure: Z-W-Y, wherein Z and Y are independently a one to eight amino acid sequence wherein the amino acids are selected from glycine and alanine and W is a non-hydrolyzable pHis analogue. Such peptides can be...  
WO/2013/109675A3
The invention provides di-peptide conjugated antitumor agents, pharmaceutical compositions and methods for preparation and use thereof for treating various cancer and inflammation-related diseases and conditions. The present invention ad...  
WO/2013/137569A1
The present invention relates to a tetrapeptide represented by the following chemical formulas 1 and 2, and a skin antiaging, skin wrinkle alleviating and anti-inflammatory cosmetic composition containing the same as an active ingredient...  
WO/2013/133032A1
 Provided are a superior dipeptidyl peptidase-IV inhibitor and the like. Specifically provided are a dipeptidyl peptidase-IV inhibitor, a hypoglycemic agent and a vascular endothelial dysfunction inhibitor, each comprising, as an act...  
WO/2013/133031A1
 Provided are a superior dipeptidyl peptidase-IV inhibitor and the like. Specifically provided is a peptide comprising the sequence Val-Pro-X (therein, X represents an amino acid residue other than an L-proline residue). Preferably, ...  
WO/2013/132317A1
The present invention relates to novel peptidomimetic compounds as therapeutic agents capable of inhibiting the programmed cell death 1 (PD1) signalling pathway. The invention also relates to derivatives of the therapeutic agents. The in...  
WO/2013/129801A1
The present invention relates to a novel tripeptide, expressed by the following formula 1, and to a cosmetic composition comprising same as an active ingredient for preventing skin aging, reducing skin wrinkles, whitening, and anti-infla...  
WO/2013/129220A1
The present invention provides a pharmaceutical, pharmaceutical composition, or food in which a dipeptide comprising Met (M) or an analog thereof and His (H) or an analog thereof is an active ingredient, as well as a method and use for p...  
WO/2013/128003A1
The present invention is related to N-terminally fatty acid modified peptides or oligopeptides and pharmaceutical compositions comprising such.  
WO/2013/125622A1
The purpose of the present invention is to provide an excellent dipeptidyl peptidase-IV inhibitor and others. A dipeptidyl peptidase-IV inhibitor, a hypoglycemic agent or an agent for preventing vascular endothelial dysfunction, each of ...  
WO/2013/126017A1
The present invention relates to organogels and emulsions based on ultrasmall self-assembling peptides. It further relates to methods for producing such organogels and emulsions as well as to the use of the organogels and emulsions in bi...  
WO/2013/125879A1
The present invention relates to an antibody to VanA or VanB ligase and to a quantification method for VanA or VanB ligase using the antibody, and also relates to a detection kit and a detection method for bacteria resistant to glycopept...  
WO/2013/124701A2
The present invention relates to conformationally constrained homo- and heterodimeric mimetics of Smac with function as inhibitors of Inhibitor of Apoptosis Proteins (IAPs), the invention also relates to the use of these compounds in the...  
WO/2013/064830A3
The invention provides a molecule that inhibits or prevents an interaction between a Src family kinase and an androgen or estradiol receptor, for use in preventing or treating a non-cancerous condition in which an activity of AR and/or E...  
WO/2013/120371A1
A compound as represented by formula I is provided, wherein groups are defined in the description. The compound is used as HCV protease inhibitor for treating HCV infection.  
WO/2013/120871A1
The application describes a process for the preparation of a compound of formula (II) useful for the preparation of a viral protease inhibitor. Intermediates of the process are also claimed.  

Matches 701 - 750 out of 17,226